HK Stock Market Move | BRAINAURORA-B (06681) opened 6% higher in morning trading; multi-domain digital therapy DELIGHT study published in eClinicalMedicine

date
09:26 20/11/2026
avatar
GMT Eight
BRAINAURORA-B (06681) opened 6% higher in morning trading. As of press time, it was up 6% at HK$1.06, with a turnover of HK$961,400.
BRAINAURORA-B (06681) opened 6% higher in morning trading; as of press time, it is up 6% at HK$1.06, with a turnover of HK$961,400. On the news front, BRAINAURORA-B announced that the DELIGHT study (a multicenter, double-blind, randomized controlled trial, NCT05704270), jointly conducted by the group with Professor Ma Changsheng's team at Beijing Anzhen Hospital Affiliated to Capital Medical University and Professor Wang Jiguang's team at Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, was officially published on November 18, 2026 in eClinicalMedicine (2025 Journal Impact Factor: 12.8, Q1), a sub-journal of The Lancet and a top international academic journal. According to the introduction, the study is the first to focus on the population with hypertension complicated by mild cognitive impairment (MCI), systematically evaluating the intervention effects of 12-week multi-domain adaptive computerized cognitive training (MD-CCT), and combining ultra-high-field 7T magnetic resonance imaging (MRI) technology to reveal the potential mechanism by which digital cognitive therapy works through the "brain-heart axis." Cognitive training not only improves patients' cognitive function, but also significantly improves cardiovascular issues such as heart rate in hypertensive patients, meaning that "training the brain" effectively reduces cardiovascular load.